Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > what happens with nasdaq listing
View:
Post by Griz_Online on Dec 15, 2016 1:40pm

what happens with nasdaq listing

Are they gonna do a share rollaback ?
Comment by Kensin1953 on Dec 15, 2016 1:50pm
Kiss of death. Vote against reverse split. It's only weeks before it get's pulled back down.  it's seldom the shares outstanding ( unless 5-600million) The market perceives a value say $1.25  you reverse 2 for 1 and get it to $2.50 and 60 dsys alter it's $1.25 again. Seen it a hundred times on the Venture. The only thing that works is a catalyst.  The downgrades ...more  
Comment by lscfa on Dec 15, 2016 2:29pm
.... who needs the frigging Nasdaq...MSL has 11 analysts following, MSLI has 2 analysts following
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities